You are here: Industry Insights > Market News > NMPA releases 2nd group of key projects for China’s drug regulatory science action plan

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

NMPA releases 2nd group of key projects for China’s drug regulatory science action plan

October 25, 2021

Tag: NMPA , drug regulatory , products

Favorites

The National Medical Products Administration (NMPA) issued a list of the second group of key projects for China's drug regulatory science action plan based on the summary of the implementation of the first group on June 24.

Departments and related affiliated institutions of the NMPA were urged to speedily formulate implementation plans in accordance with related requirements and to further improve their drug regulatory capacities, so as to speed up the marketization of innovative products and better meet the needs of public health.

Previous:Emergency Physicians: We Must Address Vaccine Hesitancy, Correct Misinformation to End Pandemic

Next:Phlow receives approval to join BARDA CDMO network

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

NMPA releases 2nd group of key projects for China’s drug regulatory science action plan | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

sterility test for pharmaceutical products

Tray Dryers for Drying Seeds & Agro Products

Electronic hardware plastic tray container specializing in the production of plastic products 21 pil

Health care products PVC blister inner tray Flocking blister tray Injection plastic tray Oral liquid

Plastic products, electronic hardware, plastic trays, food blister trays, oral liquids, inner trays,

world best selling products high quality papaya juice powder

Natural Products Organic Wintergreen Oil With OEM ODM

Spirulina Products

plant extract hot new products for 2015 bamboo leaf tea

Chinese Lab Water Cooling Products 50L -40℃ Air Cooled Chillers

NMPA releases 2nd group of key projects for China’s drug regulatory science action plan

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>